Background: Chitosan oligosaccharide, the degradation products of chitin, was reported to have a wide range of
Introduction
Hepatoma is a common malignancy and its incidence is recently rising in the developing world. More than 700,000 new cases are diagnosed throughout the world and more than 600,000 deaths are due to hepatoma each year (Renumathy et al., 2012) . Conservative chemotherapy is not efficient for hepatoma patients because of drug resistance and toxic side effects (Meng et al., 2012) . Therefore, it is urgent to find a novel therapeutic drug.
Chitosan oligosaccharide (COS), obtained by hydrolysis or degradation of chitin (Xu et al., 2007) , has 3-10 saccharide (N-acetyl-glucosamine or glucosamine) residues (Han et al., 2005) . Crustacean shells rich with Chitosan oligosaccharide have been used in Chinese medicine for long period. Studies indicated that chitosan oligosaccharide has a wide range of biological activities such as immunity regulation, anti-tumor, antioxidant and liver protection (Yin et al., 2009; Chakrabarti et al., 2004) . However, the inhibition effect of chitosan oligosaccharide on hepatoma was rarely reported.
The aim of this study was to explore the inhibition effect of chitosan oligosaccharide and the underlying mechanisms on hepatoma cells. Our study will provide an experimental basis for the clinical development of novel anti-hepatoma drug.
Materials and Methods

Cell culture
SMMC-7721 cells were obtained from ATCC. The cells were cultured in RPMI-1640 medium supplemented with 10% fetal calf serum at 37 ℃.
MTT assays
The cells （4×10 4 /well ) were plated in 96-cell plates. After treated with COS (0.5, 1.0, 1.5, 2.0, 2.5, 3.0, 3.5 and 4.0 mg/ml) for 24 h and 48 h, the viability of the cancer cells was detected by MTT assay. PBS (20 μl) and 5-Fluorouracil (5-Fu) (0.5 mg/ml) were added as the negative control and the positive control, respectively. Each concentration of COS was repeated in six wells. The cells were cultured for 24 h and 48 h and incubated with 20 μl MTT solution (5 mg/ml) for 4 h. The formazan crystals were dissolved in 150 μl DMSO and the absorbance at 589 nm was determined with a Multiskan Ascent plate reader.
Hoechst 33258 fluorescent staining to detect apoptosis
The cells (1.5×10 5 /well) were seeded into 6-well plate. After 24 h COS (2.5 mg/ml) treatment, the cells were fixed in 1 ml of 4% (V/V) formaldehyde at 4 ℃ for 10 min. Then 1 ml staining solution of Hoechst 33258 was added into each well and was kept in dark for 10 min at room temperature. The cells were observed at the wavelength of 340 nm by a fluorescence microscopy.
Cell apoptosis by flow cytometry
The cells (1.5×10 5 /well) were seeded into 6-well plate. After 24 h COS (2.5 mg/ml) treatment, the cells were harvested and washed by PBS. Then the cells were stained with Annexin-V and PI solution for 10 min in dark and analyzed by flow cytometry.
Western blot analysis
The cells were harvested and solubilized in cold RIPA buffer. Proteins were separated by SDS-PAGE and transferred to nitrocellulose (NC) membranes by semi-dry apparatus for 40 min and then blocked with blocking buffer for 1 h. The specific primary antibody 1:500 at optimized dilution was added and incubated overnight at 4 ℃. After incubation with secondary antibody 1:3000 for 2 h, protein bands were visualized by ECL kit.
Statistical analysis
Data were expressed as the mean ± SD. Data are expressed as the mean ± SD. All statistical analyses were performed with standard statistical programs SPSS 11.0. A one-way ANOVA was used for the statistical analysis. p<0.05 was considered to indicate a statistically significant difference.
Results
Effect of COS on proliferation of SMMC-7721 cell
To evaluate the effect of COS on the growth of hepatoma, the MTT assay was performed. Our results showed that COS (0.5, 1.0, 1.5, 2.0, 2.5, 3.0, 3.5, 4.0 mg/ml) significantly inhibited the proliferation of SMMC-7721 cells 
The effect of COS on the apoptosis of SMMC-7721cells
The Annexin V/PI double staining results showed that SMMC-7721 cells of the negative control group were mainly distributed in the lower left quadrant (FITC-/PI-). However with COS treatment (2.5 mg/ml), the SMMC-7721 cells were mainly distributed in the upper right quadrant (FITC+/PI+) and the late apoptotic cells increased up to 76.04% (Figure 3) . Our results indicated that the COS treatment could induce apoptosis on hepatoma cells. 
Conclusion
In conclusion, our data is the first one to indicate that COS could inhibit the growth of hepatoma cells.
Furthermore, COS can induce apoptosis which was related to the expression of down-regulated Bcl-2 and up-regulated Casepase-3. Therefore, we believed that the COS described in this study has potential to be developed as novel anti-cancer drug for hepatoma patients.
